Testicular Cancer - The Great Masquerader

Authors

  • Abhulimen Victor
  • Danagogo Okigbeye

DOI:

https://doi.org/10.47672/ajhmn.1164

Keywords:

Testicular cancer, diagnostic delay, chemotherapy.

Abstract

Purpose:  Testicular cancer is rare with increasing incidence worldwide. Testicular cancer can mimic many other diseases leading to delay in diagnosis. Delays in diagnosis and management of testicular cancer are associated with advanced stage, increased morbidity and poor prognosis. This case report aims to highlight a case of testicular cancer who presented with metastasis due to delays in testicular cancer diagnosis and ways to improve diagnosis.

Methodology: The study focused on a 17-year-old boy presented with severe intermittent abdominal pain for a month. He was reviewed by the general physicians, internists, haematologists, radiologists, general surgeons and urologists. He was given several diagnoses before he was correctly diagnosed as advanced right testicular cancer. It took a total of 31 days in a tertiary institution to reach this diagnosis.

Findings: The boy had a radical right inguinal orchidectomy. He had 4 courses of bleomycin, etoposide and cisplatin chemotherapy. He made remarkable recovery after treatment. A follow up was recommended closely with abdominal CT, and serum tumour markers (reverted to normal after treatment).

Recommendations: Prompt diagnosis of testicular cancer can reduce treatment delays. Physician education, adequate patient evaluation, investigations, and a high index of suspicion would aid diagnosis. Health awareness campaign, testicular self-examination, and good health insurance schemes would reduce patient-related factors which result in delays. Reduction in diagnostic delay is expected to improve outcome and reduce cost of management of the disease.

Downloads

Download data is not yet available.

Author Biographies

Abhulimen Victor

Urology Unit, Department of Surgery, University of Port Harcourt, Nigeria

Danagogo Okigbeye

Urology Unit, Department of Surgery, University of Port Harcourt, Nigeria

References

La Vignera S, Cannarella R, Duca Y, Barbagallo F, Burgio G, Compagnone M, et al. Hypogonadism and Sexual Dysfunction in Testicular Tumor Survivors: A Systematic Review. Front Endocrino 2019; 10.

Salako AA, Onakpoya UU, Osasan SA, Omoniyi-Esan GO. Testicular and para-testicular tumors in south western Nigeria. Afr. Health Sci 2010; 10:14-15.

Alhaji SA, Abdulkadir A, Sanusi HM. A 15-year pathologic review of testicular and paratesticular tumours in Kano, Northern Nigeria. Niger J Basic Clin Sci 2016; 13:114-8.

Abhulimen V, Raphael EJ. Testicular cancer at the University of Port Harcourt Teaching Hospital: A 10-year retrospective review. J West Afr Coll Surg 2019 Jul;9(3):21.

Chalya PL, Simbila S, Rambau PF. Ten-year experience with testicular cancer at a tertiary care hospital in a resource-limited setting: a single centre experience in Tanzania. World J Surg Oncol 2014; 12:356-7.

Marko J, Wolfman DJ, Aubin AL, Sesterhenn IA. Testicular seminoma and its mimics: from the radiologic pathology archives. RadioGraphics 2017; 37:1085-98.

Giona S. The Epidemiology of Testicular Cancer. Exon Publications. 2022 Jul 31.

Huang J, Chan SC, Tin MS, Liu X, Lok VT, Ngai CH, Zhang L, Lucero-Prisno III DE, Xu W, Zheng ZJ, Chiu PK. Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis. European Urology Oncology. 2022 Jul 19.

McGlynn KA, Trabert B. Adolescent and adult risk factors for testicular cancer. Nature Reviews Urology. 2012 Jun;9(6):339-49.

Portillo SC, Rais-Bahrami S, Magi-Galluzzi C. Updates in 2022 on the Staging of Testicular Germ Cell Tumors. Human Pathology. 2022 Aug 1.

Reynard J, Brewster S, Bier S. Oxford Handbook of Urology. Third Edition. UK: Oxford University Press,2013: 8 -14

Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, Emamekhoo H, Feldman DR, Geynisman DM, Hancock SL, LaGrange C. Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2019 Dec 1;17 (12):1529-54.

Dieckmann KP. Diagnostic delay in testicular cancer: an analytic chimaera or a worthy goal? Eur Uro 2007; 52: 1566-68. 9.

Cao D, Humphrey PA. Yolk sac tumor of the testis. J Urol 2011; 186:1475-6.

Izegbu MC, Ojo MO, Shittu LAJ: Clinicopathological patterns of testicular malignancies in Ilorin, Nigeria - a report of 8 cases. J Canc Res Ther 2005; 1:229-31.

Wei Y, Wu S, Lin T, He D, Li X, Liu J, et al. Testicular yolk sac tumors in children: a review of 61 patients over 19 years. World J Surg Oncol 2014; 12:400-9.

Ugwumba FO, Aghaji AE. Testicular cancer: Management challenges in an African developing country. S Afr Med J 2010; 100:452-5.

Kaufman M. Advanced testicular cancer in a society of racial and socio-economic health disparity. BMJ case rep 2013; doi: 10.1136/bcr-2013-009277.

Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. Guidelines on testicular cancer: 2015 update. Eur Urol 2015; 68:1054-68.

Downloads

Published

2022-08-29

How to Cite

Victor, A. ., & Okigbeye, D. . (2022). Testicular Cancer - The Great Masquerader. American Journal of Health, Medicine and Nursing Practice, 7(10), 29–33. https://doi.org/10.47672/ajhmn.1164